Search

everythinglearnresearchcommunity

for

Search:↓

Horse skin diseases are complex to manage and often require a biopsy for accurate diagnosis and treatment.

Cell transplantation faces challenges in genitourinary reconstruction, but alternative tissue sources and microencapsulation show promise.

Docetaxel and oxaliplatin are effective and have manageable side effects for recurrent platinum-sensitive ovarian cancer.

Drug repositioning is becoming more targeted and efficient with new technologies, offering personalized treatment options and growing interest in the field.

Central lipohypertrophy in HIV-infected women may lead to shorter eyelashes.

Camellia japonica extract may improve scalp health and promote hair growth.

The drug IPI-926 is safe at 160 mg daily and may help treat certain tumors, especially basal cell carcinoma.

Certain natural and synthetic compounds may help treat inflammatory skin diseases by targeting a specific signaling pathway.

The study concludes that the EDA2R gene is activated by p53 during chemotherapy but is not necessary for chemotherapy-induced hair loss.

A breast cancer patient had lasting hair loss after chemotherapy, which improved with minoxidil treatment.

Estradiol may protect ear cells from hearing loss caused by a chemotherapy drug by activating a protective pathway.

Chemotherapy causes complex changes in hair follicle cells that can lead to hair loss.

Topical thiols may prevent hair loss caused by certain chemotherapy drugs.

Human dental pulp stem cell-conditioned medium, especially from hypoxic conditions, may help treat chemotherapy-induced hair loss and does not increase cancer risk.

The document concludes that hair loss has many causes and treatments vary, including medication for pattern baldness and addressing underlying issues for other types.

Scalp cooling can prevent hair loss in 65% of chemotherapy patients, especially effective in breast cancer patients and certain chemotherapy types.

Common types of non-scarring hair loss have various causes and treatments, but more effective solutions are needed.

Low-intensity ultrasound may protect hair follicles from damage caused by a common chemotherapy drug.

Some drugs can cause reversible hair loss, but certain chemotherapy drugs may lead to permanent hair loss; drugs can also change hair color and texture.

A substance called sodium zinc dihydrolipoylhistidinate can significantly reduce hair loss caused by chemotherapy in rats.

Aromatase inhibitor therapy for breast cancer increases the risk of hair loss and thinning.

The document concludes that understanding and managing hair loss in cancer patients is important, and more research is needed for better treatments.

There is an urgent need for better treatments for hair loss caused by chemotherapy.

Some cancer treatments can cause permanent hair loss.

Hair and scalp pain is more common and severe in breast cancer patients on chemotherapy than those on tamoxifen.

TLR7-based compounds may help manage chemotherapy-induced hair loss.

Chemotherapy often causes hair loss, nail changes, and mouth issues, but these are usually manageable.

ALRN-6924 may prevent hair loss caused by chemotherapy.

Most types of hair loss can regrow naturally, but there are no effective cures for male pattern or age-related hair loss, and only limited options for females.

Melatonin may help prevent hair loss caused by the chemotherapy drug paclitaxel.